Received Jul 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
The patient did not receive the shot; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 45-year-old female patient who received HBV (Engerix B) for prophylaxis. Previously administered products included Engerix b (first dose on 31st March 2025, batch number 3X937, expiry date 31st December 2025). On an unknown date, the patient did not receive the 2nd dose of Engerix B. On an unknown date, an unknown time after receiving Engerix B, the patient experienced incomplete course of vaccination (Verbatim: The patient did not receive the shot). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 20-JUN-2025 A pharmacist called to informed of a patient that had missed the second dose of Engerix-B. She informed that the patient had the first dose in March 2025 and according to schedule the second one was supposed to be in April 2025. The patient did not receive the shot and went to the pharmacy until June 2025. The pharmacist wanted to know how to proceed in order to complete the doses of the vaccine schedule. Till the time of reporting, the patient did not receive 2nd dose of Engerix B, which led to incomplete course of vaccination.